BGI Genomics Co Ltd (300676) — Capital Reinvestment Ratio
BGI Genomics Co Ltd (300676) has a Capital Reinvestment Ratio of 0.69x as of December 2024, meaning it reinvests 1% of its operating cash flow (CN¥238.54 Million) in capital expenditures (CN¥165.34 Million). Check 300676 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
BGI Genomics Co Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks BGI Genomics Co Ltd's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see BGI Genomics Co Ltd cash conversion from operations.
Annual Capital Reinvestment Ratio for BGI Genomics Co Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for BGI Genomics Co Ltd from 2012 to 2024. See BGI Genomics Co Ltd (300676) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 5.53x | CN¥95.72 Million | CN¥529.48 Million | ▲ +82.9% |
| 2023 | 3.02x | CN¥408.77 Million | CN¥1.24 Billion | ▼ -68.7% |
| 2022 | 9.68x | CN¥130.88 Million | CN¥1.27 Billion | ▲ +6148.1% |
| 2021 | 0.15x | CN¥2.48 Billion | CN¥383.52 Million | ▲ +85.3% |
| 2020 | 0.08x | CN¥3.60 Billion | CN¥301.15 Million | ▼ -97.0% |
| 2019 | 2.79x | CN¥224.25 Million | CN¥626.44 Million | ▼ -93.9% |
| 2018 | 46.17x | CN¥14.69 Million | CN¥678.13 Million | ▲ +3761.6% |
| 2017 | 1.20x | CN¥243.66 Million | CN¥291.33 Million | ▲ +13.8% |
| 2016 | 1.05x | CN¥234.07 Million | CN¥246.01 Million | ▲ +94.9% |
| 2015 | 0.54x | CN¥328.68 Million | CN¥177.26 Million | ▼ -93.1% |
| 2013 | 7.76x | CN¥36.70 Million | CN¥284.88 Million | ▲ +809.1% |
| 2012 | 0.85x | CN¥72.49 Million | CN¥61.89 Million | — |